183 related articles for article (PubMed ID: 18266979)
1. Faecal ribosomal protein L19 is a genetic prognostic factor for survival in colorectal cancer.
Huang CJ; Chien CC; Yang SH; Chang CC; Sun HL; Cheng YC; Liu CC; Lin SC; Lin CM
J Cell Mol Med; 2008 Oct; 12(5B):1936-43. PubMed ID: 18266979
[TBL] [Abstract][Full Text] [Related]
2. Ribosomal protein l19 is a prognostic marker for human prostate cancer.
Bee A; Ke Y; Forootan S; Lin K; Beesley C; Forrest SE; Foster CS
Clin Cancer Res; 2006 Apr; 12(7 Pt 1):2061-5. PubMed ID: 16609016
[TBL] [Abstract][Full Text] [Related]
3. Factors that contribute to faecal cyclooxygenase-2 mRNA expression in subjects with colorectal cancer.
Hamaya Y; Yoshida K; Takai T; Ikuma M; Hishida A; Kanaoka S
Br J Cancer; 2010 Mar; 102(5):916-21. PubMed ID: 20145612
[TBL] [Abstract][Full Text] [Related]
4. Clinical significance of circulating tumor cells, including cancer stem-like cells, in peripheral blood for recurrence and prognosis in patients with Dukes' stage B and C colorectal cancer.
Iinuma H; Watanabe T; Mimori K; Adachi M; Hayashi N; Tamura J; Matsuda K; Fukushima R; Okinaga K; Sasako M; Mori M
J Clin Oncol; 2011 Apr; 29(12):1547-55. PubMed ID: 21422427
[TBL] [Abstract][Full Text] [Related]
5. Prognostic significance of PDCD4 expression and association with microRNA-21 in each Dukes' stage of colorectal cancer patients.
Horiuchi A; Iinuma H; Akahane T; Shimada R; Watanabe T
Oncol Rep; 2012 May; 27(5):1384-92. PubMed ID: 22267128
[TBL] [Abstract][Full Text] [Related]
6. Multivariate analysis of the prognostic value of CEA and CA 19-9 serum levels in colorectal cancer.
Reiter W; Stieber P; Reuter C; Nagel D; Lau-Werner U; Lamerz R
Anticancer Res; 2000; 20(6D):5195-8. PubMed ID: 11326694
[TBL] [Abstract][Full Text] [Related]
7. Detection of occult tumour cells in lymph nodes of colorectal cancer patients using real-time quantitative RT-PCR for CEA and CK20 mRNAS.
Oberg AN; Lindmark GE; Israelsson AC; Hammarström SG; Hammarström ML
Int J Cancer; 2004 Aug; 111(1):101-10. PubMed ID: 15185350
[TBL] [Abstract][Full Text] [Related]
8. MicroRNA-20a in human faeces as a non-invasive biomarker for colorectal cancer.
Yau TO; Wu CW; Tang CM; Chen Y; Fang J; Dong Y; Liang Q; Ng SS; Chan FK; Sung JJ; Yu J
Oncotarget; 2016 Jan; 7(2):1559-68. PubMed ID: 26621842
[TBL] [Abstract][Full Text] [Related]
9. High expression of PFTK1 in cancer cells predicts poor prognosis in colorectal cancer.
Mao Y; Jia Y; Zhu H; Wang W; Jin Q; Huang F; Zhang S; Li X
Mol Med Rep; 2017 Jul; 16(1):224-230. PubMed ID: 28498444
[TBL] [Abstract][Full Text] [Related]
10. Fecal RNA detection of cytokeratin 19 and ribosomal protein L19 for colorectal cancer.
Yang SH; Huang CJ; Lee CL; Liu CC; Chien CC; Chen SH
Hepatogastroenterology; 2010; 57(101):710-5. PubMed ID: 21033215
[TBL] [Abstract][Full Text] [Related]
11. Upregulation of kallikrein‑related peptidase 5 is associated with the malignant behavior of colorectal cancer.
Wu Y; Chen Y; Li Q; Gong Y; Liu X; Bi L; Hu C
Mol Med Rep; 2016 Sep; 14(3):2164-70. PubMed ID: 27430713
[TBL] [Abstract][Full Text] [Related]
12. Potential usefulness of detecting cyclooxygenase 2 messenger RNA in feces for colorectal cancer screening.
Kanaoka S; Yoshida K; Miura N; Sugimura H; Kajimura M
Gastroenterology; 2004 Aug; 127(2):422-7. PubMed ID: 15300574
[TBL] [Abstract][Full Text] [Related]
13. Decreased expression of semaphorin 3D is associated with genesis and development in colorectal cancer.
Wang Z; Ding M; Qian N; Song B; Yu J; Tang J; Wang J
World J Surg Oncol; 2017 Mar; 15(1):67. PubMed ID: 28320475
[TBL] [Abstract][Full Text] [Related]
14. Lymph node CEA and MUC2 mRNA as useful predictors of outcome in colorectal cancer.
Ohlsson L; Israelsson A; Öberg Å; Palmqvist R; Stenlund H; Hammarström ML; Hammarström S; Lindmark G
Int J Cancer; 2012 Apr; 130(8):1833-43. PubMed ID: 21618511
[TBL] [Abstract][Full Text] [Related]
15. Role of serum Metadherin mRNA expression in the diagnosis and prediction of survival in patients with colorectal cancer.
Abdel Ghafar MT; Gharib F; Abdel-Salam S; Elkhouly RA; Elshora A; Shalaby KH; El-Guindy D; El-Rashidy MA; Soliman NA; Abu-Elenin MM; Allam AA
Mol Biol Rep; 2020 Apr; 47(4):2509-2519. PubMed ID: 32088817
[TBL] [Abstract][Full Text] [Related]
16. Clinical significance of kallikrein-related peptidase (KLK10) mRNA expression in colorectal cancer.
Alexopoulou DK; Papadopoulos IN; Scorilas A
Clin Biochem; 2013 Oct; 46(15):1453-61. PubMed ID: 23499583
[TBL] [Abstract][Full Text] [Related]
17. SALL4 as a new biomarker for early colorectal cancers.
Ardalan Khales S; Abbaszadegan MR; Abdollahi A; Raeisossadati R; Tousi MF; Forghanifard MM
J Cancer Res Clin Oncol; 2015 Feb; 141(2):229-35. PubMed ID: 25156818
[TBL] [Abstract][Full Text] [Related]
18. Epithelial but not stromal expression of collagen alpha-1(III) is a diagnostic and prognostic indicator of colorectal carcinoma.
Wang XQ; Tang ZX; Yu D; Cui SJ; Jiang YH; Zhang Q; Wang J; Yang PY; Liu F
Oncotarget; 2016 Feb; 7(8):8823-38. PubMed ID: 26741506
[TBL] [Abstract][Full Text] [Related]
19. Overexpression of Transcription Termination Factor 1 is Associated with a Poor Prognosis in Patients with Colorectal Cancer.
Ueda M; Iguchi T; Nambara S; Saito T; Komatsu H; Sakimura S; Hirata H; Uchi R; Takano Y; Shinden Y; Eguchi H; Masuda T; Sugimachi K; Yamamoto H; Doki Y; Mori M; Mimori K
Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S1490-8. PubMed ID: 26036188
[TBL] [Abstract][Full Text] [Related]
20. Prognostic Significance and Diagnostic Value of Overexpressed lncRNA PVT1 in Colorectal Cancer.
Pan X; Cheng R; Zhu X; Cai F; Zheng G; Li J; Gao C
Clin Lab; 2019 Dec; 65(12):. PubMed ID: 31850702
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]